Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Inoue, US
Heather Inoue, Oak Park, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090155274 | HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 06-18-2009 |
| 20100034818 | Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 02-11-2010 |
| 20110040076 | Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 02-17-2011 |
| 20110091476 | Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors - This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided. | 04-21-2011 |
Junichi Inoue, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110186065 | Frontal Hairpiece - A frontal hairpiece for providing a naturally-appearing augmented frontal hairline when applied to the wearer. A frontal foundation has a forward edge, a rearward edge, a first end and a second end. The frontal foundation is thin, flexible and made from a net-like construction which substantially blends with the skin color of the wearer. The forward edge traces a tortuous pathway from approximately the first end to approximately the second end. Embodiments may include an elastic band portion connected to the frontal foundation, with first and second rear strap portions disposed therebetween. Hair is attached to the frontal foundation in a first density pattern which mimics a natural transition of a wearer's forehead into a frontal hairline. The first density pattern of some embodiments may be characterized by a greater density of hair strands applied proximate the rearward edge of the frontal foundation compared to the density of hair strands applied proximate the forward edge. | 08-04-2011 |
Keiichi Inoue, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110189308 | METHODS TO TREAT NEURODEGENERATIVE CONDITIONS OR DISEASES BY TARGETING COMPONENTS OF A PTEN SIGNALING PATHWAY - The disclosure provides that components of a PTEN cell signaling pathway may be utilized as therapeutic targets for treating, preventing, slowing the progression of or delaying the onset of a neurodegenerative disease or disorder. Such components that may be targeted include, phosphatase and tensin homologue (PTEN), glycogen synthase kinase 3 beta (GSK3β), and AKT. The subject matter disclosed herein relates to the therapeutic use of inhibitors of PTEN, inhibitors of GSK3β, or activators of AKT to treat a neurodegenerative disease or disorder in a subject. Compounds are disclosed which may be used in the methods provided. | 08-04-2011 |
Kosuke Inoue, Corona Del Mar, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090241960 | DUAL HIGH AND LOW PRESSURE BREATHING SYSTEM - A breathing system allows a single valve and corresponding control system to utilize either high or low pressure gas input and control the delivery of gas to a patient in a manner independent of the gas pressure level. Some such systems include a blower that provides gas with low pressure, a high pressure inlet port, a force balance valve or similar that will regulate the high pressure to work in the low pressure system, and a proportional valve assembly with a unitary control system that will allow for efficient ventilation operations regardless of gas source. Some such systems are capable of seamless transition from low to high pressure and from high to low pressure gas sources, as well as independent operation while either source serves as an input. | 10-01-2009 |
Riku Inoue, Stanford, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090132385 | METHOD AND SYSTEM FOR MATCHING USER-GENERATED TEXT CONTENT - According to a computer implemented method and system for matching user-generated text content, users “freely” specify content by means of fed-in texts which are matched automatically, according to rules in the embodiment. An embodiment of the invention allows customers to specify what items or services to request or offer by adding, to the “MyHaves” or “MyWants” selection criteria, using typed-in descriptions. Traditionally, for the purpose of matching supplies and demands, the specification of an individual's “wants” and “haves” is done by selecting options that are predefined by, or hard-coded into, the system's “drop-down menu”—rather than allowing customers to freely define what they want or have. This method under consideration, however, provides an efficacious solution: customers are free to request an item or service by entering standard descriptive texts describing what s/he wants in a customizable manner very akin to the flexibility associated with verbal speech, with the assurance that these human-entered texts will be matched automatically. Similarly, a customer is free to offer an item or service in the aforementioned (text-descriptive) way. The entered texts are in the form of a specific human language (e.g. English, Chinese, etcetera) using the desired input device, such as a computer keyboard. The system algorithm of an implementation then “crawls” through the network of user generated texts (user-defined texts) to find matches between what people are offering and what others are requesting, while watching out for typographical errors (in the text content) made by customers. That is to say, the algorithm in the embodiment scours the texts in the “MyWants” section of requesters and sees if there are corresponding matches found in the “MyHaves” section of offerers, while paying attention to certain system rules. | 05-21-2009 |
Takayo Inoue US
| Patent application number | Description | Published |
|---|---|---|
| 20100311840 | ORAL FORMULATIONS OF BIS(THIOHYDRAZIDE AMIDES) - Disclosed herein are oral formulations of bis(thio-hydrazide amides) compounds of the following structural formula (I): or a pharmaceutically acceptable salt thereof, wherein R | 12-09-2010 |
Takayo Inoue, Malden, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080269340 | BIS (thio-hydrazide amide) salts for treatment of cancers - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 10-30-2008 |
| 20090281172 | BIS(THIO-HYDRAZIDE AMIDE) SALTS FOR TREATMENT OF CANCERS - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 11-12-2009 |
| 20100324143 | BIS(THIO-HYDRAZIDE AMIDE) SALTS FOR TREATMENT OF CANCERS - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 12-23-2010 |
| 20110059893 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 03-10-2011 |
Tsuyoshi Inoue US
| Patent application number | Description | Published |
|---|---|---|
| 20110209994 | PROTECTIVE SHEET AND USE THEREOF - A protective sheet (for example, a protective sheet for masking during plating) is provided that has an excellent balance of adherence to the surface of an adherend and easy releasability when heat and pressure bonded. The protective sheet includes a substrate and a pressure-sensitive adhesive (PSA) layer which is provided on one side of the substrate. The PSA layer is thermoplastic. When the protective sheet is pressure bonded to a polyimide film at a temperature of 120° C. and a pressure of 0.34 MPa for a pressing time of 5 seconds, the protective sheet has a peel strength PS | 09-01-2011 |